Introduction {#S1}
============

Instances of Shigellosis infection were estimated to be about 170 million annually during the end of last century with about 1 million reported deaths in the developing countries. Although this number has decreased, shigellosis still presents itself as one of the most important pandemic diseases in the world ([@B56]).

Shigellosis is caused by the bacteria of the genus *Shigella* having four pathogenic serogroups (*Shigella dysenteriae*, *Shigella flexneri*, *Shigella sonnei*, and *Shigella boydii*). Infection is common by feco-oral route due to the intake of contaminated water and food ([@B7]). Although WHO recommends antibiotics like azithromycin, ciprofloxacin \[a fluoroquinolone (FQ)\] or one of the three second-line antibiotics, pivmecillinam, and ceftriaxone (a third-generation cephalosporin) for the shigellosis treatment, extensive use of these antibiotics has contributed to the emergence of FQ and multidrug-resistant *Shigella* species in several countries ([@B54]; [@B60]; [@B67]; [@B46]; [@B57]; [@B45]; [@B48]). Thus, recurrent changes in antimicrobial resistance profile of *Shigella* isolates poses complications in recommending standard drugs for effective treatment of the disease. Currently, the most predominant species in endemic regions was *S. flexneri* followed by *S. sonnei*, *S. boydii*, and *S. dysenteriae* which may be responsible for causing diarrheal outbreak ([@B49]; [@B46]).

Bacteriophages are specific bacterial viruses that at first attach to and then destroy their hosts through phage genome replication and bacterial lysis. These characteristics of phages hint at their applications as therapeutic agents against bacterial infections of humans and animals. The fact that, unlike antibiotics, phages can destroy target bacteria specifically without killing the normal microflora. It is crucial for the application of phages to inhibit specific bacterial growth, which can be a natural, non-toxic and active substitute for antibiotic therapy ([@B47]; [@B26]). In view of the enormous rise in antibiotic resistance in several clinically significant bacterial species, use of lytic phages is gaining more and more attention as a therapeutic alternative in the place of antibiotics against infectious diseases.

However, numerous challenges have to face during application of phage therapy in human diseases due to the limited available information regarding the interaction between phage and the host ([@B28]). Again, for the application of phage therapy, it is necessary to isolate new phages that are yet to be cultivated, active against circulating strains and to determine their physiological and genomic characters in detail for assessing their suitability.

Several bacteriophages against *Shigella* spp. have been reported. Temperate bacteriophages such as SfI(38,389 bp), SfII(41,475 bp), Sf6(39,043 bp), SfIV(39,758 bp), SfV(37,074 bp), and SfX(37,355 bp) ([@B43]; [@B25]; [@B2]; [@B13]; [@B29]; [@B55]) that are responsible in serotype conversion of *S. flexneri* have been reported. The lytic Shigella phages SF9, SP18 and ØSboM-AG3 are specific against *S. dysenteriae*, *S. sonnei*, and *S. boydii*, respectively. One broad spectrum Shigella phage pSf-1 was reported few years back that was specific against *S. flexneri*, *S. sonnei*, and *S. boydii*; another recently discovered phage vB_SsoS-ISF002 can infect both *S. flexneri* and *S. sonnei* but broad spectrum lytic phage that infects both *S. flexneri* and *S. dysenteriae* has not been reported yet ([@B3]; [@B19]; [@B36]; [@B6]; [@B32]; [@B52]).

Generally phages acquire and contribute genes, not only to other phage genomes but also to bacterial genomes and thus these are powerful factors in the evolution, physiology, and pathogenicity of the host bacteria. Here, we report the isolation and detailed characterization of a novel bacteriophage *Sfin-1*, which shows strong lytic activity against multidrug-resistant isolates of *S. flexneri*, *S. dysenteriae*, and *S. sonnei.* Discovery of new phage against *Shigella* spp. and their genomics would not only help to develop phage based therapy against the shigellosis, but also to understand the evolution strategy, the mosaic architecture of phages and the involvement of genes(s) if any, in host pathogenesis.

Materials and Methods {#S2}
=====================

Bacterial Strains and Antimicrobial Resistance Tests {#S2.SS1}
----------------------------------------------------

This study included a total number of 40 multidrug-resistant clinical isolates of *S. flexneri*, *S. dysenteriae*, *S. boydii*, *S. sonnei*, *Salmonella enterica serovar* Typhi, various *Escherichia coli* strains like K12, AG100, XL1 Blue, and *E. coli* C. All *Shigella* and *Salmonella* species were isolated from patient's stool samples at Bacteriology Division of National Institute of Cholera and Enteric Diseases (NICED), "Kolkata" and reported thereafter ([@B46]; [@B18]). They were then grown in nutrient broth medium at 37°C for 24 h for further tests adhering to the biosecurity and institutional safety procedures under Biosafety Level II (BSL II).

Isolation and Purification of Bacteriophages {#S2.SS2}
--------------------------------------------

Water sample was collected from the Ganga River, near Serampore, Hooghly district, about 25 km from Kolkata, in the state of West Bengal, India. After the removal of particulate matters with filter paper (Whatman 1), the water sample was mixed with *S. flexneri* 2a strains, 10% (w/v) peptone and it was incubated at 37°C for 24 h to enrich the concentration of bacteriophages. The enriched culture was then mixed with 1% (w/v) chloroforms and was shaken well to remove the bacterial debris. The mixture was centrifuged and supernatant was filtered through 0.22 μm pore membrane (Millipore, United States). This supernatant was inoculated (10 μL) as spot on the soft agar plate mixed with *S. flexneri* 2a strains. Clear zone around the spot indicated the presence of specific bacteriophage in the water sample against *S. flexneri* 2a. Similarly, other isolated serotypes of *Shigella* spp. were also checked for determination of phage specificity.

Collected water sample was then subsequently used for plaque assay; 100 μL of filtrate and 200 μL *S. flexneri* 2a culture (OD600 = 0.3) was mixed with 3.5 mL soft agar (0.9%) and plated onto LB hard agar (1.8%) plate. This plate was incubated in 37°C for 24 h. Clear individual plaques formed on the plate were transferred to another *S. flexneri* 2a plate. A single plaque was transferred into 500 μL phage dilution medium (0.1% tryptone, 0.85% sodium chloride) and stored at 4°C for 24 h. The suspended phage solution was then allowed for another round of plaque assay. Thus a single plaque was transferred at least three times to purify the bacteriophage. After that, phage dilutions and plaque assay was performed to get confluent lysis plates. The soft agar layer was then scrapped out, suspended in cold phage dilution medium and kept on ice for 3 h. It was then centrifuged at 5,000 × *g* and the supernatant was collected. The phage lysate prepared by this procedure was then pelleted at 68,000 × *g* for 2 h at 4°C in an ultracentrifuge since phage precipitates produced thus has more titer values. For further purification, cesium chloride (CsCl) density gradient centrifugation was done (ρ = 1.3, 1.5, 1.7 g/mL) at 100,000 × *g* for 3 h at 4°C and the phage band obtained between 1.7 and 1.5 g/mL was collected. The phage particles were recovered from the band and were dialyzed against TM buffer (50 mM Tris--Cl, pH 8.0 containing 10 mM MgSO~4~) and stored at 4°C for further studies ([@B58]).

Host Range {#S2.SS3}
----------

The strains to be tested were grown overnight in nutrient broth 3.5 mL of the molten soft agar (0.7% w/v) was mixed with 100 μL of the bacterial cell suspension and this mixture was overlaid onto the surface of solid basal LB Agar (1.5% w/v). 10 μL (about 1.0 × 10^10^ PFU/mL) of the phage suspension was spotted on the plate and it was then incubated at 37°C, overnight. Bacterial sensitivity to a bacteriophage was determined by bacterial lysis at the spot where the phage suspension was inoculated. Each test was repeated three times. According to the degrees of clarity, the spots were differentiated into two categories: clear (+), and no reaction (−) ([@B9]; [@B15]).

Thermal and pH Stability {#S2.SS4}
------------------------

For thermal stability testing, 16 × 10^12^ *Sfin-1* phage particles were incubated at 4, 37, 50, 60, 70, 80, 90°C in 1 mL and for each temperature aliquots (100 μL) were taken after 5, 15, 40, 60 min to be titered by the double layered agar plate method against *S. flexineri* 2a. For pH stability testing, 14 × 10^10^ *Sfin-1* phage particles were kept in 1 mL of TM buffers (50 mM Tris, 10 mM MgSO~4~) at pH range of 2--12 (adjusted with HCl or NaOH for acidic or alkaline range, respectively) for 1 h at 37°C and then aliquots (100 μL) from each pH were titered by the double-layered agar plate method against *S. flexineri* 2a ([@B68]; [@B41]).

Bacterial Challenge Test {#S2.SS5}
------------------------

Minimum inhibitory concentrations (MICs) of different antibiotics for three clinical *Shigella* isolates were determined. According to the CLSI guidelines ([@B17]) the isolates were multi drug resistant. Bacteriolytic activity of phage *Sfin-1* was determined as described by [@B61] with some modifications. Cells of *S. flexneri* 2a *(1A)* (strain ID BCH5722, [Table 1](#T1){ref-type="table"}) and *S. dysenteriae*1 *(1A)* (strain ID BCH5762, [Table 1](#T1){ref-type="table"}) were allowed to grow in presence of ampicillin (32 μg/mL), chloramphenicol (32 μg/mL), tetracycline (16 μg/mL), cotrimoxazole (25 μg/mL), nalidixic acid (32 μg/mL), ciprofloxacin (4 μg/mL), norfloxacin (16 μg/mL), and ofloxacin (8 μg/mL), whereas *S. sonnei* (strain ID BCH7084, [Table 1](#T1){ref-type="table"}) was grown in presence of tetracycline (16 μg/mL), cotrimoxazole (25 μg/mL), and nalidixic acid (32 μg/mL). 20 mL of cultures (OD600 = 0.3) were harvested by centrifugation and resuspended in fresh 1 mL of LB. Thereafter phage *Sfin-1* was added at an multiplicity of infection (MOI) of 0.1, 0.01, and 0.001, allowed for adsorption for 5 min (*S. flexneri 2a* and *S. dysenteriae1*) or 10 min (*S. sonnei*) at 37°C. Each mixture was then transferred to 20 mL of fresh LB. Aliquots were taken at specific time intervals for 5 h and the number of bacterial cells was monitored by spread plate method. As negative control bacterial cultures were inoculated with phage dilution medium and respective antibiotics.

###### 

Susceptibility test for various clinically isolated antibiotic resistant strains to the phage *Sfin-1*, isolated from river Ganges water samples Kolkata, India.

  **Sl. no**   **Strain ID**   **Bacterial isolates with different serotypes**   **Antimicrobial resistance profile by disc diffusion method**   **Lysis by *Sfin-1***
  ------------ --------------- ------------------------------------------------- --------------------------------------------------------------- -----------------------
  1            BCH5722         *Shigella flexneri 2a (1A)*                       ACTQNaCipNorOfx                                                 \+
  2            BCH4025         *Shigella flexneri 2a (2A)*                       ACQ                                                             \+
  3            BCH3651         *Shigella flexneri 2a (3A)*                       ACTQ                                                            \+
  4            BCH3557         *Shigella flexneri 2a (4A)*                       CTQNa                                                           \+
  5            BCH7151         *Shigella flexneri 2a (5A)*                       ACTQNaCipNorOfx                                                 \+
  6            BCH5762         *Shigella dysenteriae 1(1A)*                      ACTQNaCipNorOfx                                                 \+
  7            BCH5848         *Shigella dysenteriae 1(2A)*                      ACTQNaCipNorOfx                                                 \+
  8            BCH5859         *Shigella dysenteriae 1(3A)*                      ACTQNaCipNorOfx                                                 \+
  9            BCH5912         *Shigella dysenteriae 1(4A)*                      ACTQNaCipNorOfx                                                 \+
  10           BCH5946         *Shigella dysenteriae 1(5A)*                      ACTQNaCipNorOfx                                                 \+
  11           BCH7084         *Shigella sonnei (1)*                             TQNa                                                            \+
  12           BCH7264         *Shigella sonnei (2)*                             TQNa                                                            \+
  13           BCH3143         *Shigella boydii (1)*                             TQNa                                                            −
  14           BCH4324         *Shigella boydii (2)*                             TQNa                                                            −
  15           BCR62           *Salmonella enterica serovar* Typhi *(1)*         NaCipNorAzm                                                     −
  16           BCR43           *Salmonella enterica serovar* Typhi *(2)*         NaAzm                                                           −
  17                           *Escherichia coli K12*                                                                                            −
  18                           *Escherichia coli* C                                                                                              \+
  19                           *Escherichia coli AG100*                                                                                          −
  20                           *XL1 Blue*                                                                                                        −

A, ampicillin; C, chloramphenicol; T, tetracycline; Q, cotrimoxazole; Na, nalidixic acid; Cip, ciprofloxacin; Nor, norfloxacin; Ofx, ofloxacin; Azm, azithromycin.

One Step Growth Curve {#S2.SS6}
---------------------

One step growth experiments were carried out by a method described elsewhere ([@B15]; [@B42]) with modification. Briefly, *Shigella* spp. (*S. flexneri* 2a *(1A)*, *S. dysenteriae* 1 *(1A)*, *S. sonnei*) were grown in LB medium at 37°C. Then 20 mL of *Shigella* culture (OD600 = 0.3) was harvested by centrifugation (5,000 × *g*, 4°C, 10 min). The pellet was resuspended in 1 mL of fresh LB and phage *Sfin-1* was added to Shigella culture at a MOI of 0.01. The mixture was incubated for maximum adsorption (5 min for *S. flexneri* 2a and *S. dysenteriae* 1, 7 min for *S. sonnei*) at 37°C followed by 10^4^-fold of dilution at final volume of 10 mL. During incubation at 37°C, 100 μL of aliquots were taken at different time intervals up to 100 min, mixed with 200 μL of *S. flexineri 2a* culture, plated on double-layered agar for phage titration. Three independent experiments were run for each *Shigella* spp. Burst size was determined as a ratio of the average bacteriophage particles produced after the burst and the average number of phage particles adsorbed.

Genome Analysis of Phage *Sfin-1* {#S2.SS7}
---------------------------------

Bacteriophage DNA was isolated from purified phages (procedure described above), using the phage DNA isolation kit (Norgen, Canada) according to the manufacturer's instruction with modifications ([@B10]). Whole genome sequencing of *Sfin-1* was performed by ION Xpress (S5-00205) version 5.0.4. The count of read was 67,228 with the average length of 322 bp per read. The sequence data could be assembled into a single contig of 50,403 bp using SPAdes 3.8.0 ([@B8]). The nucleotide sequence of the genome of *Sfin-1* was submitted at GenBank under accession number MF468274. The nucleotide sequences of the phage *Sfin-1* were auto annotated by GeneMarkS^[1](#footnote1){ref-type="fn"}^ (Ver 3.26) ([@B11]) and the function of the proteins encoded by the coding sequences (CDSs) were predicted based on BLASTp program and conserved domain search^[2](#footnote2){ref-type="fn"}^. The probable replication origin of *Sfin-1* was predicted by GenSkew program^[3](#footnote3){ref-type="fn"}^. Putative promoter regions were predicted using Neural Network Promoter Prediction tool of the Berkeley Drosophila Genome Project^[4](#footnote4){ref-type="fn"}^ (minimum promoter score: 0.9). Rho-independent transcription terminators were identified using ARNOLD terminator finding program ([@B37]). tRNA scan--SE search program^[5](#footnote5){ref-type="fn"}^ was used to detect Putative tRNAs, if any ([@B40]). Whole genome comparisons were made with Mauve^[6](#footnote6){ref-type="fn"}^. Sequences of tail fiber proteins were compared by using the online Protein Predict Tool ([@B64]).

Electron Microscopy {#S2.SS8}
-------------------

The phage suspension (about 1 × 10^12^ PFU/mL) was negatively stained with 2% (w/v) uranyl-acetate and then examined under a FEI Tecnai 12 Bio Twin Transmission Electron Microscope at an operating voltage of 200 kV.

Identification of Proteins Associated With *Sfin-1* Virions {#S2.SS9}
-----------------------------------------------------------

A total of 100 μL (1 × 10^18^ PFU/mL) purified phage was diluted with 50 mM NH~4~HCO~3~. It was then treated with 100 mM DTT at 95°C for 1 h followed by 250 mM iodoacetamide at room temperature in dark for 45 min. The sample was then digested with Trypsin and incubated overnight at 37°C. The peptides were extracted in 0.1% formic acid and incubated at 37°C for 45 min. The solution thus prepared was centrifuged at 10,000 × *g* and the supernatant was vacuum dried and dissolved in 20 μL of 0.1% formic acid in water. 10 μL of it was subjected to ACQUITY UPLC BEH C18 column (Waters, United Kingdom) for separation of peptides; the peptides separated on the column were directed to Waters Synapt G2 Q-TOF instrument (Waters, United Kingdom) for MS and MS/MS analysis. The raw data was processed using MassLynx 4.1 WATERS. The individual peptides MS/MS spectra were matched to the database sequence for protein identification on PLGS software, Waters. The obtained spectrometry information was analyzed with PLGS software 3.0.2 (Waters, United Kingdom) using the National Centre for Biotechnology Information (NCBI) non-redundant database and the specific database created in this study based on the predicted CDSs of phage *Sfin-1*. The important parameter settings for the PLGS analysis were as follows: peptide mass tolerance (ppm), 50; fragment mass tolerance (ppm), 100; maximal missed cleavages, 2.

Determination of the Bacteriophage Genome Ends {#S2.SS10}
----------------------------------------------

The identification of phage packaging strategies and genome ends of a bacteriophage can be obtained by comparative analysis of phylogenetic relationships of amino acid sequences of terminase large subunit of phage with the other phages of known packaging strategies ([@B63]; [@B4]). The phylogenetic tree was thus reconstructed using the large terminase amino acid sequence of the phages and the relationships among the phage *Sfin-1* and with the other phages were analyzed.

The predicted amino acid sequences of the large terminase subunits genes of the phages were collected from NCBI and were used for phylogenetic analysis. The bacteriophages involved into this study have been molecularly analyzed and contains well characterized ds DNA bacteriophages with different types of packaging strategies dependent on terminase actions (headful, 5′-extended cos ends, 3′-extended cos ends and direct terminal repeats). All the sequences were aligned using ClustalW in MEGA7 with default parameters. Phylogenetic tree was built using the neighbor-joining method and phylogenies were determined by bootstrap analysis of 1,000 replicates in MEGA 7.0 version ([@B21]).

Additionally the genome ends were determined as described by Amarillas and Leon-Felix ([@B4]). To detect the presence of circularly permutated terminally redundant genome ends, approximately 1 μg phage DNA was digested with specific restriction enzymes (*Bgl*II, *Mlu*I) according to the manufacturer's guidelines (NEB, United States). After 2 h of incubation at 37°C the digests were heated to 80°C for 15 min and then cooled fast in ice or slow at room temperature and allowed to run on agarose gel (0.8% w/v) in TAE electrophoresis buffer. The gel was stained with ethidium bromide and visualized with UV illumination. GeneRuler 1 kb Plus DNA Ladder (Thermo Fisher Scientific, United States) was used as DNA molecular weight marker.

Phage Receptor Identification {#S2.SS11}
-----------------------------

The receptor properties of *Sfin-1* were determined as describe previously with some modifications ([@B35]). To check the effect of proteinase K on adsorption of phage *Sfin-1*, *S. flexneri 2a*, *S. dysenteriae 1*, and *S. sonnei* cultures (OD600 = 0.3) were treated with proteinase K (250 mg/mL, SRL) at 55°C for 2 h, washed and allowed for adsorption assay at an MOI of 0.0001 as described above. In order to study whether periodate can inhibit *Sfin-1* and hosts interaction, the following experiment was performed. *S. flexneri 2a*, *S. dysenteriae1*, and *S. sonnei* cultures were centrifuged at 5,000 × *g* for 5 min, bacterial pellets were resuspended into sodium acetate (50 mM, pH 5.2) in presence or absence of 200 mM NaIO~4~ and incubated for 2 h (protected from light). After incubation the cells were washed and performed adsorption assay.

To ensure that the possible effect was not due to the incubation of host cells at 55°C, a control experiment without proteinase K was also performed. LB medium was used as a non-absorbing control for both assays. The phage titer in the control supernatant was set to 100%.

Statistical Analysis {#S2.SS12}
--------------------

For the thermal stability assays, the difference in the titer values taken between 0 and 60 min were calculated for each temperature. Then the titer value difference for each temperature was compared to that of 4°C using Student's *t*-test. Two way ANOVA test was performed to analyze the data of Bacterial challenge test. Student's *t*-tests were performed to analyze the data of phage receptor identification. All statistical analysis were performed by software GraphPad Prism 7.0.

Results and Discussion {#S3}
======================

Isolation of Bacteriophage {#S3.SS1}
--------------------------

Several environmental water samples from ponds, creeks, streams, and canal ways were collected and the presence of phage that infects *Shigella* spp. was tested according to the method described in "Materials and Methods" section. The water sample from the River Ganges, Kolkata (located near Serampore, Hooghly of West Bengal, India) was found to contain phage, designated as *Sfin-1* that could grow in antibiotic resistant various strains of *Shigella* spp. and resulted in clear lytic plaques with size ranging from 1.5 to 2.0 mm in diameter and well defined boundaries in the lawn of the bacteria ([Figure 1A](#F1){ref-type="fig"}). Purification of the virion was done by CsCl density gradient ultracentrifugation after plaque purification and phage propagation as described in "Materials and Methods" section. The transmission electron microscopy (TEM) photos and the genome organization (described below) suggest that only one type of phage was present into the purified sample. If more than one bacteriophage were present there, then more genes of specific phage proteins such as tape measure protein and large terminase subunit would have been expected.

![*Shgella* spp. specific phage *Sfin-1* and its morphology. **(A)** Plaques of *Sfin-1* in the lawn of *Shigella flexneri 2a*. The phage particles were prepared, negatively stained and examined by electron microscope as described in "Materials and Methods" section. **(B,C)** The electron micrograph presented as broad view of the phage in 100 and 200 nm scale, respectively.](fmicb-10-01876-g001){#F1}

Broad Host Range {#S3.SS2}
----------------

The ability to lyse various pathogenic *Shigella* spp. of newly isolated phage was analyzed by the spot test. The strains belonging to the Shiga toxin producing clinical isolates of *S. flexneri*, *S. dysenteriae*, *S. boydii*, *S. Sonnei* were used. Other enteropathogens like *Salmonella typhi* and various *E. coli* strains like K12, AG100, XL1 Blue and *E. coli* C. were also checked. The *Shigella* serovars are resistant to multiple antibiotics (amoxicillin, chloramphenicol, tetracycline, ciprofloxacin, norfloxacin, nalidixic acid, cotrimoxazole, ofloxacin, and azithromycin) ([@B5]) ([Table 1](#T1){ref-type="table"}). Phage suspensions produced clear zones of lysis in case of various serotypes of *S. flexneri*, *S. dysenteriae*, *S. sonnei*, and *E. coli* C., but no reaction was observed for other species.

Our host range studies suggest that *Sfin-1* is a newly isolated phage with a broad lytic spectrum. The wide host range infectivity against various *Shigella* isolates shows that *Sfin-1* is a polyvalent phage on *Shigella*, known human and animal pathogen and *E. coli* C. Although phages are commonly very specific infecting only a single species of bacteria, some polyvalent phages have also been described ([@B27]).

From the Ganges River that flows through the city of Kolkata, we isolated the phage *Sfin-1* near Serampore, Hooghly. Since *Shigella* spp. is communicated to human by fecal-oral route, the isolation of phage *Sfin-1* indicates fecal contamination of the river. This lytic phage is active against a broad host range of antibiotic resistant strains of *S. flexneri*, *S. dysenteriae*, and *S. sonnei.* This is the first report of bacteriophage that is lytic against three pathogenic *Shigella* spp. and *E. coli* C. Therefore, it can be an excellent choice for phage therapy against antibiotic resistant Shigellosis.

Phage Morphology {#S3.SS3}
----------------

The phage *Sfin-1* which is specific against various antibiotic resistant *Shigella* spp. was purified and subjected to TEM. The TEM study suggested that this phage has an isometric head (61 nm in diameter) and a non-contractile tail (approximately 155 nm) with which a basal tuft is attached ([Figures 1B,C](#F1){ref-type="fig"}). The mature phage does not have neck, base plate, spikes, or fiber. According to the guidelines of the International Committee on Taxonomy of Viruses ([@B20]), which is based on virion morphological features, the phage *Sfin-1* was assigned to the family *Siphoviridae* in the order *Caudovirale*s. More than 95% of the phages reported so far grouped into the order Caudovirales (tailed phages). According to the classification system of [@B1], most (60%) of the bacteriophages belong to the family *Siphoviridae* with flexible and long tails. So the phage *Sfin-1* belongs to this taxonomic classification.

Bacterial Challenge Test {#S3.SS4}
------------------------

With the addition of phage *Sfin-1* at an MOI of 0.001, 0.01, and 0.1 to mid-exponential phase cells (OD600 = 0.3) in *in vitro* culture conditions, challenge tests were performed to investigate the ability of phage *Sfin-1* to lyse multidrug-resistant *S. flexneri 2a (1A)* (Strain Id BCH5722, [Table 1](#T1){ref-type="table"}) in presence of antibiotics ampicillin, chloramphenicol, tetracycline, cotrimoxazole, ciprofloxacin, norfloxacinand ofloxacin ([Figure 2A](#F2){ref-type="fig"}). In each case, control experiment was performed where bacterial cells were grown only in presence of respective antibiotics and phage suspension buffer without phage particles. The viability of bacterial cells was significantly decreased when infected with MOI of 0.1, 0.01, and 0.001. The two way ANOVA tests for multiple comparisons showed that the mean differences between the cell lysis data for all three MOIs and control are highly significant (*P* \< 0.0001). Within one and half hours after phage addition, cells were started to decrease rapidly and complete lysis occurred within two and half hours in case of MOI of 0.1 and 0.01. But in case of 0.001, complete lysis occurs after 3 h. Similar results were observed for *S. dysenteriae1 (1A)* (Strain ID BCH5762, [Table 1](#T1){ref-type="table"}) in presence of the same antibiotics as mentioned above ([Figure 2B](#F2){ref-type="fig"}) and *S. sonnei* (Strain ID BCH7084) cells in presence of tetracycline, cotrimoxazole, and nalidixic acid ([Figure 2C](#F2){ref-type="fig"}). The *in vitro* challenge tests established that the phage *Sfin-1* could be used to inactivate the multidrug-resistant pathogenic strains of *Shigella* and therefore, it could be useful as biocontrol agent. The efficacy of this phage in controlling *Shigella* infection however has to be determined by *in vivo* studies. It is important to mention that a host population known as bacterial insensitive mutants (BIMs) that can resist lysis may emerge and grow again long after phage treatment ([@B69]; [@B65]; [@B4]). Use of phage cocktail with more than one phage that follows different infection mechanisms may solve this problem ([@B65]).

![Bacterial challenge test of phage *Sfin-1* on different clinical isolates of *Shigella* spp. Clinically isolated species of **(A)** *Shigella flexneri 2a*, **(B)** *Shigella dysenteriae* 1, and **(C)** *Shigella sonnei* were grown (OD600 = 0.3) in 20 mL LB in presence of several antibiotics as described in "Materials and Methods" section, hervested by centrifugation, resuspended in 1 mL LB medium and infected with *Sfin-1* at an MOI of 0.1, 0.01, and 0.001. After adsorption, the cultures were diluted 21 fold in LB and incubated for 5 h with shaking at 37°C. At different time intervals, viability of *Shigella* spp. was determined by spread plate method. As negative control *Shigell* spp. were grown in absence of *Sfin-1* in presence of antibiotics. Two way ANOVA indicated significant difference between control and *Sfin-1* infected sets (*P* \< 0.0001, *n* = 3).](fmicb-10-01876-g002){#F2}

So the result of host cell lysis caused by phage *Sfin-1* showed that MOI is directly related to cell death. If higher number of phages are applied on cells, destabilization of the outer membrane occurs, which in turn causes cell lysis. Since it is not the result of phage replication and release, it is called "lysis from without" ([@B12]; [@B4]). In [Supplementary Table S1](#TS1){ref-type="supplementary-material"} phage *Sfin-1* is compared with other 44 Shigella phages so far reported in the NCBI database. Only 26% of the isolated Shigella phages have been characterized till date.

Infectivity of *Sfin-1* {#S3.SS5}
-----------------------

Thermal stability test was carried out with *Sfin-1* at pH 7.0 in order to investigate the heat resistant capability of the phage. The activity of phage *Sfin-1* remained moderately same when warmed at 37°C or 50°C for 5 min. Activity decreased significantly into 0.1--0.01% when incubated at 60°C or 70°C for 5 min (*P* \< 0.005). When heated at 80°C or 90°C for 5 min only 0.001% activity was retained (*P* \< 0.005). Most of the phages remained active even after 60 min incubation at 37°C or 50°C, whereas only 0.1 and 0.01% phages were active after 60 min incubation at 60 and 70°C, respectively (*P* \< 0.005), the phage activity remarkably decreased at 80°C or 90°C after 60 min incubation (*P* \< 0.0005). This result suggests that the phage *Sfin-1* is moderately stable toward heat stress at both 37 and 50°C ([Figure 3A](#F3){ref-type="fig"}).

![Stability of phage *Sfin-1* in wide temperature and pH range. **(A)** Thermal stability of phage *Sfin-1* at various temperatures as indicated. *Sfin-1* phage particles (16 × 10^12^) were incubated at different temperatures in 1 mL and for each temperature the number of infectious phage particles was determined from 100 μL aliquots from various time points by plaque assay against *S. flexineri* 2a. Result was plotted as mean ± SD (*n* = 3). **(B)** pH stability of phage *Sfin-1*. In 1 mL of TM buffer having different pH *Sfin-1* phage particles (14 × 10^10^) were incubated at 37°C for 1 h and the number of infectious phage particles from each sample was determined with 100 μL aliquots by plaque assay against *S. flexineri* 2a. Result was plotted as mean ± SD (*n* = 3).](fmicb-10-01876-g003){#F3}

The *Shigella* infection commonly happens in intestine where the pH is somewhat acidic. In order to control *Shigella* with *Sfin-1* in human intestine, it is therefore, essential to know its pH stability. Highest activity was observed after 1 h incubation at pH 7.0 at 37°C, while reduction of activity was observed at different pH. Around 42.7% or 10.8% recovery of infectious phage *Sfin-1* was found at pH 5.0 and 12.0, respectively. This result suggested that extreme pH as well as lower pH though affect the phage stability but a remarkable fraction of *Sfin-1* remained active ([Figure 3B](#F3){ref-type="fig"}). Rapid absorption, moderate thermal and pH stability therefore indicate that this phage may be applied for therapeutic purpose. However, in order to achieve therapeutic efficacy the phages must be delivered to the small intestine through encapsulation otherwise it may not survive at low gastric pH ([@B59]).

One-Step Growth Curve {#S3.SS6}
---------------------

The one step growth curve performed at 37°C for *Sfin-1* propagated on *S. flexneri* 2a and *S. dysenteriae*1 showed a latent period of about 5 min and the average burst size was 27--28 PFU/cell ([Figure 4](#F4){ref-type="fig"}). While in case of *S. sonnei*, the latent period was 10 min and the average burst size was estimated to be 146 PFU/cell. A phage with a large burst size can have practical advantage in therapy, because within a short period of time phage population can increase its initial dose by several 100 folds ([@B22]).

![One step growth curve of bacteriophage *Sfin-1. Shigella flexneri 2a*, *Shigella dysenteriae 1*, *Shigella sonnei* were infected with *Sfin-1* at 37°C at an MOI of 0.01. After phage absorption, the cultures were diluted 10^4^-fold, incubated at 37°C and the titers in PFU per mL of *Sfin-1* from the infected cultures at different time points were determined. Result was plotted as mean ± SD (*n* = 3). **(A--C)** Present one step growth curves of *Sfin-1* in *Shigella flexneri 2a*, *Shigella dysenteriae 1*, and *Shigella sonnei*, respectively.](fmicb-10-01876-g004){#F4}

Whole Genome Phylogenetic and Synteny Study {#S3.SS7}
-------------------------------------------

For better understanding of phage *Sfin-1* biology, its genome was sequenced. The whole genome sequencing study by Ion torrent reveals that the *Sfin-1* genome size is 50,403 bp with 45.20% GC content, close to 50.9% of the host's chromosome ([@B62]). The Genome of *Sfin-1* shows total 82 protein CDSs after auto-annotation with GeneMarkS; 19 of which are rightward in orientation while others are leftward ([Figure 5A](#F5){ref-type="fig"}). Among them 23 had annotated function ([Table 2](#T2){ref-type="table"}). No tRNA was found in the *Sfin-1* genome; this suggests that upon entry into the host, phage is completely dependent on the host tRNA for its protein synthesis.

![Genome organization of *Sfin-1*. **(A)** The *Sfin-1* genome map was schematically presented. The predicted CDSs are indicated as arrows, the orientation of which shows the transcription. With different colors predicted molecular function for CDS of virion morphogenesis (green arrows), DNA metabolism and replication (red arrows), DNA packaging (yellow arrows), cell lysis (violet arrows), hypothetical proteins (blue arrows), putative promoters (pink) are denoted. **(B)** Comparative genomic maps of phage *Sfin-1*, pSf-2, Shfl1 was constructed using the Mauve progressive alignments to determine conserved sequence regions. This alignment resulted into two large synteny locally collinear blocks (LCBs) with 28,894 bp (red) and 16,173 bp (green), one small LCB with 5,334 bp (sky), indicating DNA regions which are homologous among the genomes. Graphs inside the blocks show high similarity between the genomes. There are some non-identical genome regions which are denoted with white color inside the blocks. Although there seems to be genomic rearrangement, the block sequence remains the same across the genomes of all phages.](fmicb-10-01876-g005){#F5}

###### 

Features of the protein coding sequences of bacteriophage *Sfin-1* and homology to protein database.

  **CDSs**   **start**   **Stop**   **Length (bp)**   **Predicted Functions**                                      **Best BLASTp match and Identity (%)**                                      **Conserved protein domain family**   
  ---------- ----------- ---------- ----------------- ------------------------------------------------------------ --------------------------------------------------------------------------- ------------------------------------- ----------------------------------------------
  CDS1       703         2          702               Hypothetical protein                                         Hypothetical protein ISF001_0035 \[Shigella phage vB_SsoS-ISF002\]          100                                   
  CDS2       1240        764        477               Phage protein                                                Hypothetical protein Shfl1p34\[Shigella virus Shfl1\]                       92                                    
  CDS3       2364        1252       1113              Phage capsid and scaffold                                    Major capsid protein \[Shigella phage SH6\]                                 99                                    pfam09979 COG3566
  CDS4       3026        2367       639               Phage minor capsid protein                                   Minor capsid protein \[Shigella phage SH6\]                                 99                                    COG2369 pfam04233TIGR01641
  CDS5       3127        3011       117               Phage minor capsid protein                                   Minor capsid protein \[Shigella phage SH6\]                                 97                                    
  CDS6       4400        3117       1284              Phage portal protein                                         Putative portal protein \[Shigella virus Shfl1\]                            98                                    pfam06381 TIGR01555COG3567
  CDS7       6025        4457       1569              Phage terminase, large subunit                               Putative terminase large subunit \[Shigella virus Shfl1\]                   99                                    COG5410 TIGR0160COG5362 pfam03237
  CDS8       6589        6065       525               Phage terminase, small subunit                               Putative terminase small subunit \[Shigella virus Shfl1\]                   99                                    pfam16677
  CDS9       6886        6674       213               Phage protein                                                Hypothetical protein JMPW1_023 \[Escherichia phage JMPW1\]                  97                                    
  CDS10      7087        6902       186               Phage protein                                                Hypothetical protein pSf2_045 \[Shigella phage pSf-2\]                      98                                    
  CDS11      7229        7068       162               Phage protein                                                Hypothetical protein pSf2_046 \[Shigella phage pSf-2\]                      98                                    
  CDS12      7597        7394       204               Phage protein                                                Hypothetical protein pSf2_047 \[Shigella phage pSf-2\]                      97                                    
  CDS13      7827        7597       231               Phage protein                                                Hypothetical protein JMPW1_019 \[Escherichia phage JMPW1\]                  100                                   
  CDS14      8171        7827       345               Phage protein                                                Hypothetical protein B508_00140 \[Escherichia phage ADB-2\]                 95                                    
  CDS15      8377        8168       210               Phage protein                                                Hypothetical protein JMPW2_017 \[Escherichia phage JMPW2\]                  99                                    
  CDS16      9022        8450       573               JK_59P                                                       Hypothetical protein T1p62 \[Escherichia virus T1\]                         97                                    
  CDS17      9134        9024       111               Phage protein                                                Hypothetical protein \[Escherichia phagevB_EcoS_SH2\]                       92                                    
  CDS18      9607        9131       477               3′-phosphatase, 5′-polynucleotide kinase, phage-associated   3′-phosphatase, 5′-polynucleotide kinase \[Escherichia phagevB_EcoS_SH2\]   95                                    cd07502 PHA02530 pfam03767TIGR01675
  CDS19      10193       9747       447               Phage protein                                                hypothetical protein SH6_0017 \[Shigella phage SH6\]                        85                                    
  CDS20      11283       10627      657               Phage protein                                                Hypothetical protein \[Escherichia phagevB_EcoS_SH2\]                       78                                    
  CDS21      11567       11280      288               Hypothetical protein                                         Hypothetical protein pSf2_056 \[Shigella phage pSf-2\]                      97                                    
  CDS22      11811       11551      261               hypothetical protein                                         Hypothetical protein B508_00105 \[Escherichia phage ADB-2\]                 96                                    
  CDS23      12075       11926      150               Phage protein                                                Hypothetical protein \[Escherichia phagevB_EcoS_SH2\]                       96                                    
  CDS24      12560       12075      486               Phage protein                                                Hypothetical protein T1p70\[Escherichia virus T1\]                          88                                    
  CDS25      13135       12632      504               Phage protein                                                Hypothetical protein B508_00095 \[Escherichia phage ADB-2\]                 88                                    
  CDS26      13338       13132      207               Hypothetical protein                                         Hypothetical protein Shfl1p10 \[Shigella virus Shfl1\]                      99                                    
  CDS27      13600       13409      192               Hypothetical protein                                         Hypothetical protein JMPW2_006 \[Escherichia phage JMPW2\]                  96                                    
  CDS28      13783       13610      174               Phage protein                                                Hypothetical protein pSf2_062 \[Shigella phage pSf-2\]                      98                                    
  CDS29      13890       13780      111               Phage protein                                                Hypothetical protein SH6_0007 \[Shigella phage SH6\]                        100                                   
  CDS30      14114       13887      228               Phage protein                                                Hypothetical protein B508_00085 \[Escherichia phage ADB-2\]                 99                                    
  CDS31      14351       14121      231               Phage protein                                                Hypothetical protein B508_00080 \[Escherichia phage ADB-2\]                 91                                    
  CDS32      14900                  14430             Phage protein                                                Hypothetical protein \[Escherichia phagevB_EcoS_SH2\]                       90                                    
  CDS33      15097       14903      195               Phage protein                                                Hypothetical protein Shfl1p02 \[Shigella virus Shfl1\]                      100                                   
  CDS34      15703       15188      516               Phage protein                                                Hypothetical protein Shfl1p01 \[Shigella virusShfl1\]                       90                                    
  CDS35      16391       16603      213               Hypothetical protein                                         Hypothetical protein \[Escherichia phagevB_EcoS_SH2\]                       100                                   
  CDS36      16600       17304      705               Phage protein                                                DNA methylase \[Shigella phage SH6\]                                        97                                    COG0270
  CDS37      17370       17705      336               Hypothetical protein                                         Hypothetical protein SH6_0079 \[Shigella phage SH6\]                        93                                    
  CDS38      17779       17940      162               Hypothetical protein                                         Hypothetical protein Shfl1p82 \[Shigella virus Shfl1\]                      92                                    
  CDS39      17970       18386      417               Phage protein                                                Hypothetical protein JMPW1_074 \[Escherichia phage JMPW1\]                  93                                    
  CDS40      18379       18579      201               Phage protein                                                Hypothetical protein T1p02 \[Escherichia virus T1\]                         98                                    
  CDS41      18596       18949      354               Phage protein                                                Hypothetical protein pSf2_078 \[Shigella phage pSf-2\]                      99                                    
  CDS42      19133       19357      225               Phage protein                                                Hypothetical protein \[Escherichia phagevB_EcoS_SH2\]                       97                                    
  CDS43      19361       19570      210               Phage protein                                                Hypothetical protein B508_00010 \[Escherichia phage ADB-2\]                 100                                   
  CDS44      19651       20067      417               Phage protein                                                Hypothetical protein B508_00005 \[Escherichia phage ADB-2\]                 98                                    
  CDS45      20144       21712      1569              Phage protein                                                Hypothetical protein \[Escherichia phagevB_EcoS_SH2\]                       100                                   
  CDS46      21717       22124      408               Phage protein                                                Hypothetical protein \[Escherichia phagevB_EcoS_SH2\]                       99                                    
  CDS47      22314       22529      216               hypothetical protein                                         Hypothetical protein SH6_0068 \[Shigella phage SH6\]                        94                                    
  CDS48      22946       22542      405               Phage protein                                                Hypothetical protein T1p11 \[Escherichia virus T1                           89                                    
  CDS49      23431       22943      489               Phage lysin (EC 3.2.1.17)                                    Endolysin \[Shigella phage SH6\]                                            99                                    cd00737 COG3772 pfam00959
  CDS50      23709       23431      279               Phage holin                                                  Hypothetical protein T1p14 \[Escherichia virus T1\]                         100                                   
  CDS51      23941       23765      177               Phage protein                                                Hypothetical protein B508_00370 \[Escherichia phage ADB2\]                  99                                    
  CDS52      25156       24005      1152              Phage protein                                                Hypothetical protein pSf2_07 \[Shigella phage pSf-2\]                       97                                    
  CDS53      25540       25235      306               JK_65P                                                       Hypothetical protein pSf2_07 \[Shigella phagepSf-2\]                        94                                    
  CDS54      25926       25717      210               Phage protein                                                Hypothetical protein B508_00360 \[Escherichia phage ADB-2\]                 94                                    
  CDS55      26244       25993      252               Phage protein                                                Hypothetical protein B508_00355 \[Escherichia phage ADB-2\]                 99                                    
  CDS56      26954       26241      714               DNA adenine methyltransferase, phage-associated              DNA N-6-adenine-methyltransferase \[Escherichia phage ADB-2\]               98                                    TIGR01712pfam05869
  CDS57      27438       27022      417               Phage protein                                                VRR-NUC domain-containing protein \[Escherichia phage ADB-2\]               100                                   pfam08774 smart00990
  CDS58      29453       27435      2019              DNA helicase, phage-associated                               Putative ATP-dependent helicase \[Shigella virus Shfl1\]                    99                                    COG 1062 cd18799 pfam 0851
  CDS59      29548       30000      453               Phage protein                                                Hypothetical protein Shfl1p58 \[Shigella virus Shfl1\]                      99                                    pfam1549
  CDS60      30061       30996      936               DNA primase                                                  DNA primase/helicase \[Escherichia phage JMPW1\]                            99                                    smart00778 pfam08273 COG4643 pfam02655
  CDS61      31097       32881      1785              Phage tail fiber protein                                     Putative tail fiber \[Shigella virus Shfl1\]                                94                                    pfam 13884 PHA 00430
  CDS62      33323       32910      414               Phage protein                                                Hypothetical protein Shfl1p55 \[Shigella virus Shfl1\]                      98                                    
  CDS63      34017       33370      648               Phage-associated recombinase                                 Putative recombination protein \[Shigella phage vB_SsoS-ISF002              98                                    
  CDS64      35156       34092      1065              Phage exonuclease                                            Hypothetical protein B508_00305 \[Escherichia phage ADB-2\]                 99                                    pfam12684
  CDS65      35683       35913      231               Hypothetical protein                                         Hypothetical protein pSf2_020 \[Shigella phage pSf-2\]                      97                                    
  CDS66      35916       36872      957               Phage protein                                                Hypothetical protein pSf2_021 \[Shigella phage pSf-2\]                      99                                    
  CDS67      40349       36900      3450              Tail fiber protein                                           Putative tail fiber protein \[Shigella virus Shfl1\]                        98                                    COG 4733 pfam13550
  CDS68      41026       40427      600               Phage tail assembly protein                                  Tail assembly protein \[Escherichia phageJMPW1\]                            100                                   COG 4723 pfam 06805
  CDS69      41757       41023      735               Phage tail assembly protein                                  Tail assembly protein \[Escherichia phageJMPW1\]                            99                                    cd 8073 pfam 00877
  CDS70      42566       41754      813               Minor tail protein                                           Putative minor tail protein \[Escherichia phage JMPW2\]                     99                                    pfam05100 COG 4672 TIGR01600
  CDS71      42968       42615      354               Tail fiber protein                                           Tail fiber protein \[Escherichia phage JMPW1\]                              99                                    pfam 05939 COG4718
  CDS72      43038       42955      84                Phage tail length tape-measure protein 1                     Putative tail tape measure protein \[Shigella virus Shfl1\]                 96                                    pfam06791COG5281 TIGR01541pfam09718 PRK03918
  CDS73      45842       43035      2808              Phage tail length tape-measure protein 1                     Putative tail tape measure protein \[Shigella virus Shfl1\]                 98                                    pfam06791COG5281 TIGR01541pfam09718 PRK03918
  CDS74      46152       45883      270               Phage protein                                                Hypothetical protein pSf2_028 \[Shigella phage pSf-2\]                      99                                    
  CDS75      46517       46200      318               Phage protein                                                Hypothetical protein ISF001_0027 \[Shigella phage vB_SsoS-ISF002\]          99                                    
  CDS76      47299       46631      669               Phage tail fibers                                            Tail fiber protein \[Escherichia phage JMPW1\]                              97                                    pfam08813
  CDS77      47699       47301      399               JK_18P                                                       Hypothetical protein pSf2_031 \[Shigella phage pSf-2\]                      99                                    
  CDS78      48132       47689      444               Phage protein                                                Hypothetical protein pSf2_032 \[Shigella phage pSf-2\]                      97                                    
  CDS79      48496       48125      372               JK_22P                                                       Hypothetical protein pSf2_033 \[Shigella phage pSf-2\]                      98                                    
  CDS80      48906       48496      411               JK_23P                                                       Hypothetical protein B508_00220 \[Escherichia phage ADB-2\]                 98                                    
  CDS81      49238       48951      288               JK_24P                                                       Hypothetical protein ISF001_0033 \[Shigella phage vB_SsoS-ISF002\]          97                                    
  CDS82      50247       49288      960               Phage protein                                                Hypothetical protein B508_00210 \[Escherichia phage ADB-2\]                 98                                    

The whole genome Basic Local Alignment Search Tool (BLAST) analysis of *Sfin-1* against the NCBI data base showed that *Sfin-1* is related to two phages i.e., Shigella phage Shfl1 (GenBank accession number: NC_015456) and Shigella phage pSf-2 (GenBank accession number: KP085586). The phage *Sfin-1* genome sequence shares 91 and 92% nucleotide identity with Shigella phages Shfl1 and pSf-2, respectively. Genomic features of three phages ware compared in [Supplementary Table S2](#TS2){ref-type="supplementary-material"}. Though the genome sizes, GC contents, number of transcription terminator sequences and CDSs are quite similar and genes of predicted structural and functional proteins share high degree of homology, they are differently arranged and their orientations are sometimes opposite ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). Maximum differences present into their hypothetical proteins which are uncharacterized according to database. Around 75% genes of *Sfin-1* are of unknown functions while most of them have \>80% homology with their counterparts in Shfl1 and Psf-2 genome. Since these phages were isolated from different geographical locations, the high degree of similarity probably appears from their complex evolutionary relationships with their common host *S. flexineri* ([@B53]). Since the genome of *Sfin-1* diverges from the other phage genomes, with similarity searches only a fraction (28.04%) of protein functions could be predicted emphasizing the novelty of this phage. Therefore, a thorough investigation is needed to fully understand its biology. The mauve alignment of *Sfin-1*, Shfl1 and pSf-2 resulted into two large synteny locally collinear blocks (LCBs) with 28,894 bp (red) and 16,173 bp (green), one small LCB with 5,334 bp (sky), indicating DNA regions which are homologous among the genomes. Graphs inside the blocks show high similarity between the genomes. There are some non-identical genome regions which are denoted with white color inside the blocks. Although there seems to be genomic rearrangement, the block sequence remains the same across the genomes of all phages.

Moreover the alignment of the three phages also demonstrated that some regions are highly homologous with significant rearrangements ([Figure 5B](#F5){ref-type="fig"}). This indicated that these phages share a common genome organization although positions of the genes are different.

Module Analysis {#S3.SS8}
---------------

The annotated proteins of *Sfin-1* can be categorized into the following functional groups: DNA metabolism and replication proteins; this module presents in the middle part of the *Sfin-1* genome. They are 3′-phosphatase, 5′-polynucleotide kinase/CDS18, Phage associated N-6-DNA adenine-methyl transferase/CDS56, DNA helicase/CDS58, DNA primase/helicase/CDS60, and phage associated recombinase/CDS63, phage exonuclease/CDS64). The 3′-phosphatase, 5′-polynucleotide kinase belongs to the family that includes the C-terminal domain of the bifunctional enzyme T4 polynecleotide kinase/phosphatase PNKP. The PNKP phosphatase domain can catalyze the hydrolytic elimination of the 3′-phosphoryl group of DNA, RNA and deoxynucleoside 3′-monophosphates. The enzyme N-6-DNA adenine-methyl transferase (DAM) is involved in methylation of GATC sequence of its own DNA to protect it from exonuclease. The counterpart of this enzyme of *Sfin-1* is present in Escherichia phage ADB-2 (99% identity). There are two helicase coding genes in the *Sfin-1* phage genome; one is ATP dependent and has 99% identity with Shigella phage Shfl1 helicase and another is primase associated having 99% identity with Escherichia phage JMPW1. The primase/helicase protein has a zinc finger motif at its N terminal region and ATP binding region at its C-terminal part with origin recognition property. CDS63 contains a protein which encodes phage associated recombinase domain that is commonly found associated with Pfam04404 of ERF superfamily. The family includes single strand annealing proteins (SSAPs), such as Rad52, ERF, Red-beta, and RecT that function in RecA independent and RecA dependent DNA recombination pathways. This type of phage encoded recombinase are mainly involved in horizontal gene transfer by homologous recombination, thus promotes gene shuffling among phages which accelerates evolution. The phage exonuclease acts together with recombinase and involves into replication process from fork structures as well as in nucleotide metabolism. CDS64 encodes an exonuclease VIII that is related to PDDEXK superfamily. Thus 3′-phosphatase, 5′-polynucleotide kinase, phage recombinase, exonuclease are involved in DNA metabolism and recombination process of the phage genome after entering into host cells.

Sequenced based prediction of the phage *Sfin-1* genome identified that upstream and downstream cluster genes are involve in viral head morphogenesis and tail component formation, respectively. CDS3, CDS4, and CDS5 which are likely to produce phage capsid and scaffold protein belong to Phage Mu F like protein family. Members of this family are required for viral head morphogenesis. CDS6 encodes head and tail junction portal protein that is believed to form the pore through which genome is packaged into the prohead and is also a part of the packaging motor ([@B39]). CDS7, CDS8 encode phage large and small subunit, respectively, which are involved in packaging of the concatameric DNA in phage capsids ([@B44]). Apart from upstream genes, the downstream genes CDS61, CDS67, CDS70, CDS71, CDS72, CDS73, and CDS 76 probably encode the tail component whereas CDS68 and CDS69 direct the synthesis of protein responsible for tail assembly. CDS72 and CDS73 that encodes tail tape measure protein is the second largest gene of the phage genome. Although genomes of phages *Sfin-1*, Shfl1 and pSf-2 were found to be highly similar as discussed above, they infect different species ([Supplementary Table S2](#TS2){ref-type="supplementary-material"}). As tail fiber proteins are involved in host range determination ([@B66]), the sequence and predicted features of three phages' tail fiber proteins were compared. Four tail fiber proteins of *Sfin-1* are (A) CDS61, (B) CDS67, (C) CDS71, and (D) CDS76. Their counterparts in Shfl1 are CDS53 (93.60% identity), CDS47 (98% identity), CDS43 (95.73% identity), CDS39 (96.85% identity), respectively and in pSf-2 are CDS16 (97.31% identity), CDS22 (98% identity), CDS26 (94.02% identity), CDS30 (100% identity), respectively. The tail fiber proteins of these phages not only share high degree of nucleotide sequence homology, the positions of helix and strands in them are also very similar.

However, 69, 116, 239, 277, 313, 345, 380, 415, 483, and 545 of tail fiber protein A, 43, 48, 72, 101, 152, 158, 190, 198, 199, and 1,089 for tail fiber protein B, 8, 61, and 67 for tail fiber protein C amino acid residues of *Sfin-1* sequence differ to those in phages Shfl1 and Psf-2, which might result in differences in their protein binding regions ([Supplementary Figures S2](#FS2){ref-type="supplementary-material"}--[S5](#FS5){ref-type="supplementary-material"}) and ultimately determine the changes in host specificity. No difference of amino acid residue of tail fiber protein D sequence has been noticed.

Tail length of the lambdoid phages corresponds to the length of the tail tape measure protein where single amino acid is equivalent to ∼0.15 nm ([@B34]). According to this hypothesis the tail length of the phage *Sfin-1* is approximately about 144 nm long which is approximately close to our measured length 155 nm. Most of the virion morphogenesis genes encode proteins which show similarity to either Shigella phage psf-2 or Shigella virus Shfl1 encoded proteins. However, gene order of Shfl1 is totally reverse to the *Sfin-1* while psf-2 possesses the same gene orientation but at different positions. The terminase subunits and CDS7-CDS8, the DNA packaging genes of *Sfin-1* have counterparts in Shigella phage Shfl1 with 99% identity. These proteins are mainly involved in ATP dependent DNA packaging system.

Cell lysis proteins, phage lysine/CDS49 and holin/CDS50 are present in *Sfin-1* phage genome. These genes are crucial for host cell destruction during burst step of phage life cycle. Once the new phage progeny has been assembled, most of the phages lyse their host by using a dual lysis system, which contains a pore forming protein holin and cell wall degrading enzyme phage lysozyme or endolysin. CDS49 and CDS50 located contagiously at the middle part of the *Sfin-1* genome that are involved in cell lysis. CDS49 encodes 162 amino acids long phage lysozyme/endolysin belonging to the pfam00959 family found in dsDNA phages. Members of this family in conjunction with holin (CDS50) cleave the ß1,4-glycosidiclinkage of polysaccharide present in the bacterial membrane ([@B70]). BLASTp analysis also indicates the presence of one DNA binding transcriptional regulatory cro protein encoded by CDS59 belonging to the HTH_XRE superfamily. *Sfin-1* may use this protein to regulate transcriptional timing in the gene expression. So presence of lysis genes but no lysogeny related genes into the *Sfin-1* genome clearly indicates that this phage is a potent lytic phage. The GeneSkew program, an application for computing and plotting nucleotide skew data predicted the probable replication origin of *Sfin-1*. The GC-skew plot ([Figure 6](#F6){ref-type="fig"}) indicates that the replication origin could be the region around the nucleotide 34201 (close to CDS64).

![Cumulative GC skew analysis of *Sfin-1* genome sequence. The cumulative graph displays the global minimum and maximum. The window size of 1,000 bp and a step size of 100 bp were used to calculate the global minimum and maximum. The blue and red lines represent the GC-skew and the cumulative GC-skew, respectively. The putative origin of replication (9,401 nt) and the putative terminus location (34,201 nt) can be predicted from the minimum and maximum of a GC-skew.](fmicb-10-01876-g006){#F6}

Proteomic Analysis {#S3.SS9}
------------------

The purified phage of *Sfin-1* was analyzed by liquid chromatography/tandem mass spectrometry (LC-MS/MS). The LC-MS/MS analysis detected 22 phage proteins including 16 structural with a coverage ranging from 10 to 25% and 6 functional with a coverage ranging from 16 to 23% ([Table 3](#T3){ref-type="table"}). Among 16 structural proteins, the phage capsid and scaffold protein, minor capsid protein, tail fiber protein, phage lysin, phage holin, minor tail protein, tail assembly protein, terminase large and small subunit are associated with virion morphogenesis and phage packaging functions while the other 6 functional proteins are phage helicase, exonuclease, recombinase, 5′ polynucleotide kinase, DNA adenine methyltransferase, primase. These proteins are involved in DNA metabolism and replication functions of the phage genome after entering into host cells. The phage encoded recombinase is mainly involved in horizontal gene transfer by homologous recombination process which helps in gene rearrangement among phages resulting in acceleration of evolution.

###### 

Virion proteins detected by LC-MS/MS.

  **CDS**   **Start**   **End**   **Mass (Da)**   **Predicted function**                     **BLASTp (best match)^1^**                    **Identity (%)^2^**   **LC-MS/MS^3^**
  --------- ----------- --------- --------------- ------------------------------------------ --------------------------------------------- --------------------- -----------------
  03        2364        1252      40117           Phage capsid and scaffold                  WP_022638357/*Lactobacillus plantarum*        10/24 (42)            25
  04        3026        2367      24234           Minor capsid                               WP_002314920/*Enterococcus faecium*           23/89 (26)            15
  05        3127        3011      432991          Phage minor capsid                         WP_024636649/*Enterococcus faecium*           10/31 (32)            13
  06        4400        3117      48011           Portal protein                             WP_009841304/*Vibrio* spp. AND4               15/38 (39)            25
  07        6025        4457      60287           Terminase large subunit                    YP_006119910/*Escherichia coli O83*           28/115 (24)           14
  08        6589        6065      19320           Terminase small subunit                    YP_006780198/*Escherichia coli O104*          11/24 (46)            13
  18        9607        9131      17985           3′-phosphatase, 5′-polynucleotide kinase   NP_268935/*Streptococcus phage 370.1*         9/12 (75)             16
  49        23431       22943     18276           Phage lysin                                YP_535193/*Lactobacillus salivarius UCC118*   5/15 (33)             19
  50        23709       23431     7577            Phage holin                                WP_061631936/*Streptococcus pneumonia*        6/15 (40)             12
  56        26954       26241     27014           DNA adenine methyltransferase              NP_268935/*Streptococcus phage 370.1*         7/22 (32)             16
  58        29453       27435     76000           DNA helicase                               WP_058540300/*Pseudomonas putida*             29/98 (30)            14
  60        30061       30996     34612           DNA primase                                WP_023241409/*Salmonella enterica*            27/76 (36)            23
  61        31097       32881     64478           Tail fiber protein                         NP_857641/*Yersinia pestis*                   13/40 (33)            10
  63        34017       33370     23935           Phage associated recombinase               WP_060441855/*Serratia marcescens*            32/126 (25)           16
  64        35156       34092     40165           Phage exonuclease                          YP_004243626/*Bacillus subtilis*              16/50 (32)            18
  67        40349       36900     127462          Tail fiber protein                         WP_010939430/*Desulfovibrio vulgaris*         109/484 (30)          21
  68        41026       40427     20880           Tail assembly protein                      WP_023658790/*Pseudomonas fluorescens*        23/73 (32)            20
  69        41757       41023     28345           Tail assembly protein                      WP_005987870/*Desulfovibrio africanus*        17/70 (24)            17
  70        42566       41754     29021           Minor Tail protein                         WP_007364011/*Opitutaceae bacterium TAV1*     7/23 (30)             18
  71        42968       42615     13041           Tail fiber protein                         WP_010939430/*Desulfovibrio vulgaris*         5/11 (45)             21
  73        45842       43035     101408          Tail-length tape measure protein           WP_063259367/*Enterobacter cloacae*           63/284 (25)           22
  76        47299       46631     24077           Tail fiber protein                         NP_857641/*Yersinia pestis*                   9/27 (33)             10

1

The matched homologs of LC-MS/MS data.

2

The percentage identity is calculated based on the number of identical amino acid residues (numerator) over the number of compared residues (denominator) and shown in parentheses.

3

The sequence coverage (%) determined by mass spectrometry of the protein is indicated.

Determination of the Bacteriophage Genome Ends {#S3.SS10}
----------------------------------------------

Whole genome sequencing followed by assembly of *Sfin-1* genome initially generated a linear 50,530 bp fragment with a 127 bp terminal repeat at both of its ends. The linear genome is expected as in tailed bacteriophages within the channel of portal protein only one dsDNA can pass and therefore, the head contains linear genome. However, linear phage genome may have different types of ends. It is known that phage terminase enzyme creates the virion DNA ends and this enzyme is one of the most conserved phage proteins within the group. Therefore, comparative analysis of terminase amino acid sequence of a phage clusters it with others that generate similar ends. According to the phylogenetic analysis of the large terminase subunit, *Sfin-1* was clustered with the terminase of *E. coli* phage ADB-2, Shigella phage Shfl1 and psf-2 which belong to T1 family of phage ([Figure 7](#F7){ref-type="fig"}). This family has double stranded terminal repeats in their chromosome ends. Based on its close relationship with the T1 like phages, it is predicted that *Sfin-1* genome is possibly circularly permutated with direct terminal repeats. For a circularly permuted headful packaging phage chromosome, the site of initiation cleavage is not precise. So, alternative initiation cuts are spread over regions on the concatemers. As a result, chromosome lengths of individual virions are imprecise. The undigested phage DNA as well as restriction pattern of these type of phages are expected to contain all the fragments from a circular genome along with a submolar pac fragment as happened with P22 genome ([@B14]) and in case of imprecise series initiation cleavage like phage sf6 and ES18, the pac fragment may not be detected. Instead a blur background will be observed because of the variable lengths of terminal fragments ([@B14]). When *Sfin-1* genomic DNA was digested with restriction endonucleases *Bgl*II and *Mlu*I, the result was in agreement with the predicted result based on a circular *Sfin-1* genome ([Figure 8](#F8){ref-type="fig"}). Restriction digests were warmed at 80°C and then cooled down slowly or rapidly. After slow cooling single stranded cohesive ends of the phage genome are expected to anneal and appear as a longer fragment in gel electrophoresis. But no difference was noticed between slow and fast cooled sets for both the enzymes indicating absence of cohesive ends in the *Sfin-1* genome. Additionally blur background was observed in electrophoresis gel. This result indicates that *Sfin-1* is a T1 like headful packaging phage.

![Phylogenetic tree of terminase large subunit. Phages with known packaging mechanisms were only included. Bootstrap analysis was performed with 1,000 repetitions. The terminase large subunits were compared in the MEGA 7.0 version using neighbor-joining method.](fmicb-10-01876-g007){#F7}

![Enzymatic analysis of *Sfin-1* genomic DNA. Phage DNA was completely digested with *Bgl*II and *Mlu*I and the products were analyzed by 0.8% agarose gel electrophoresis, Lane M indicates the 1 kb Plus DNA Ladder. F and S indicate that the digests were heated to 80°C for 15 min and then cooled fast on ice or slow at room temperature, respectively.](fmicb-10-01876-g008){#F8}

Identification of Host Receptor {#S3.SS11}
-------------------------------

The crucial step in the phage infection is its adsorption to the surface of the host through receptor. As the *Shigella* spp. belongs to the class of gram negative bacteria with complex lipopolysaccharide (LPS) and protein at its cell surface, the outer membrane carbohydrate (LPS) or protein may act as the specific receptor for phage infection. Therefore, it is very important to find out whether LPS or protein is the recognition site of phage *Sfin-1* during infection. To determine the actual receptor of the phage *Sfin-1*, outer membrane LPS and proteins of *S. flexneri* 2a, *S. dysenteriae* 1, and *S. sonnei* were degraded by periodate and proteinase K respectively prior to the infection. *Sfin-1* showed no change in infection efficiency with or without proteinase K treatment to the above mentioned hosts. In contrast, high number of phage particles remained unabsorbed when hosts were pre-treated with periodates ([Figure 9](#F9){ref-type="fig"}). So, this experiment suggests that the adsorption of phage *Sfin-1* to the host is mediated by the outer membrane complex LPS structure. When LPS is used as phage receptor, phage shows strain specificity. Here, we see *Sfin-1*, which uses LPS as receptor to infect three *Shigella* spp. This apparent anomaly may be attributed to the close relationship between *Shigella* spp. Although there is heterogeneity among LPS's O-antigens of *Shigella* spp. they share extensive similarity ([@B38]).

![*Sfin-1* infections on proteinase K and periodate treated host. The effect of proteinase K and sodium periodate on adsorption of phage *Sfin-1*. *Shigella flexneri* 2a, *Shigella dysenteriae* 1, and *Shigella sonnei* cultures (OD600 = 0.3) were treated with proteinase K (250 mg/mL) or sodium periodate (200 mM NaIO~4~) followed by *Sfin-1* (MOI 0.0001) infection. Upon centrifugation, the phage titer in supernatant was determined as described in "Materials and Methods" section. Cells suspended in LB, cells incubated at 55°C in LB and cells in acetate buffer were used as control. The results are shown as residual PFU percentages. The phage titer in the control supernatant was set to 100%. Mean ± SD of three independent experiments are indicated. To determine the significance of the differences between group means, unpaired *t*-tests were performed between the controls and the tests. ^∗^Significance level, i.e., *P* \< 0.05, "ns" indicates non-significant. **(A--C)** Results of *S. flexneri* 2a, S. *dysentariae*1, and *S. sonnei*, respectively.](fmicb-10-01876-g009){#F9}

Concluding Remarks {#S4}
==================

Multidrug-resistant *Shigella* infection has already become a critical problem in many countries. Against the backdrop of widespread antibiotic resistance, phages are re-emerging as promising therapeutic agent to control bacterial infections. In the current study we have characterized a novel thermostable and wide range pH tolerant *Siphoviridae* phage *Sfin-1* that infects and lyses the important antibiotic resistant enteropathogens *Shigella* spp. This is the first reported phage which infects both *S. flexneri* and *S. dysenteriae.* The article presents complete physical characterizations, sequence analysis and detailed genome annotation of phage *Sfin-1*. Phage structural proteins have also been identified through LC-MS/MS study. The Genomic data are important resources to study and use phages to control specific bacteria species. Phylogenetic analysis concludes that *Sfin-1* belongs to the T1-like bacteriophage and thus it may be packaged by headful packaging method. Further analysis of phage *Sfin-1* cell wall receptor revealed that, bacteriophage *Sfin-1* recognizes LPS O-antigen as its primary receptor for adsorption. Further studies on *Sfin-1* phage will be useful to apply it for therapeutic purpose against multidrug-resistant shigellosis.
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###### 

Comparative genomic analysis of *sfin-1* with Shfl1 and pSf-2. Comparison of *Sfin-1* genome with that of **(A)** Shfl1 and **(B)** pSf-2 are schematically presented. Green (virion morphogenesis), yellow (DNA packaging), red (DNA metabolism and replication), and gray (cell lysis) colors represent different groups of homologous proteins of known functions. Numbers within parentheses indicate degree of homology as calculated via tblastx. The violet arrow heads indicate *Sfin-1*-specific genes which are absent in shfl1 and pSf-2. Black arrowheads denote genes of Shfl1 and pSf-2 absent in *Sfin-1*. Hypothetical proteins having more than 90% homology are indicated by saffron color and less than 90% by sky blue color.
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Click here for additional data file.

###### 

The comparison of tail fiber protein sequence A (CDS61) of *Sfin-1*, CDS53 of Shfl1 and CDS16 of pSf-2. **(A)** The predicted features comparison of three proteins. The red diamond represents protein binding region, the red and blue rectangles represent the helix and strand of proteins, respectively. **(B)** The comparison of amino acid sequences of three proteins by ClustalW. ^∗^Represents same amino acid and blank represents different amino acids.
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Click here for additional data file.

###### 

The comparison of tail fiber protein sequence B (CDS67) of *Sfin-1*, CDS47 of Shfl1 and CDS22 of pSf-2. **(A)** The predicted features comparison of three proteins. The red diamond represents protein binding region, the red and blue rectangles represent the helix and strand of proteins, respectively. **(B)** The comparison of amino acid sequences of three proteins by ClustalW. ^∗^Represents same amino acid and blank represents different amino acids.
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Click here for additional data file.

###### 

The comparison of tail fiber protein sequence C (CDS71) of *Sfin-1*, CDS43 of Shfl1 and CDS26 of pSf-2. **(A)** The predicted features comparison of three proteins. The red diamond represents protein binding region, the red and blue rectangles represent the helix and strand of proteins, respectively. **(B)** The comparison of amino acid sequences of three proteins by ClustalW. ^∗^Represents same amino acid and blank represents different amino acids.
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Click here for additional data file.

###### 

The comparison of tail fiber protein sequence D (CDS76) of *Sfin-1*, CDS39 of Shfl1 and CDS30 of pSf-2. **(A)** The predicted features comparison of three proteins. The red diamond represents protein binding region, the red and blue rectangles represent the helix and strand of protein, respectively. **(B)** The comparison of amino acid sequences of three proteins by ClustalW. ^∗^Represents same amino acid and blank represents different amino acids.
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###### 

Comparative analysis of *Sfin-1* with different other Shigella phages available in NCBI database. NA^∗^ = no data available.
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Comparative analysis of *Sfin-1* with pSf-2 and Shfl1 genomes.
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Click here for additional data file.
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